GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug combo shows hope for slowing aggressive gut tumors
Disease control OngoingThis study tests whether adding Lutathera to standard octreotide therapy can delay tumor growth in people with advanced neuroendocrine tumors of the stomach, intestines, or pancreas. The trial involves 226 patients with fast-growing tumors (grades 2 and 3) who have not received p…
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated May 03, 2026 23:33 UTC
-
New pill shows promise for rare cancers in early trial
Disease control OngoingThis study tests a new oral drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The goal is to see if the drug can slow tumor growth or shrink tumors. Participants take the drug by mouth, and their tumors are check…
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC